Medicare Expands Its Coverage of Costly Cancer Breakthrough

(Bloomberg) -- The U.S. government will expand payment nationwide for breakthrough blood-cancer treatments from Novartis AG and Gilead Sciences Inc. whose use has by stymied by uneven reimbursement...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.